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introduction
Pterygium is epithelial hyperplasia characterized by fibrovascular tissue 
growth on the ocular surface, which grows out of conjunctiva and 
proliferates all over the cornea.
Associated with :
• exposure to ultraviolet (UV)-B, primarily affect the limbal stem cells
• Environmental involvement 
introduction
• Pterygium clinical symptoms may be mild and often with no complaints at all 
(asymptomatic). 
• Complaints  red eye, inflammation, burning sensation, and foreign body sensation
• Clinically, Donald Tan classified pterygium as : atrophic, intermediate, and fleshy.
• In practice  inflammatory and non-inflammatory 
• Formerly a chronic degenerative condition, but after the discovery of abnormal expression 
of p53 protein in the epithelium of pterygium  tumor-like uncontrolled cell proliferation
INTRODUCTION
VEGF
Vascular permeability, cell proliferation, inflammation, tissue 
remodeling and angiogenesis
Important angiogenesis factors in the mechanism of pterygium formation 
A heparin-binding vascular glycoprotein  
Polycyclic Aromatic Hydrocarbons (PAHs)  result of incomplete 
combustion of organic materials from environmental carcinogens 
Metabolized by different xenobiotic-metabolizing enzymes, one 
of which cythocrome P450 (P450 or CYP). 
Attack DNA  toxicity and cell transformation
INTRODUCTION
CYP1A1 is a sub-family 1 CYP gene superfamily  encoding enzymes metabolizing carcinogens.
Hendriati et al (2017) classified pterigium based on its clinical symptoms into inflammatory and 
non-inflammatory pterygium and found that CYP1A1 polymorphisms may occur in both pterygium 
groups although the difference is not significant 
The polymorphism of CYP1A1 was found in pteryigium tissue  carcinogenic involved in the 
pathogenesis of pterygium 
INTRODUCTION
Objective
This study aims to determine the association between 
CYP1A1m1 (rs4646903) polymorphisms with the level of 
CYP1A1 enzymes, p53 protein, and vascular endothelial growth 
factor (VEGF) in patients with inflammatory and non-
inflammatory pterygium. 
Methods
• Cross sectional study comparative study design carried out in the Department of 
Ophthalmology Dr. M. Djamil General Hospital Padang, Community Health Center 
(BKIM) Padang, and private hospitals to collect samples.
• The study population were all pterigium patients
Inclusion criteria 
• Diagnosed with primary pterigium
unilaterally and bilaterally, criteria of 
surgical indication, not receiving anti-
VEGF therapy or steroids in the last 2 
weeks, and agreed to participate in 
this study.
Exclusion criteria 
• Anterior segment infection 
(conjunctivitis and keratitis) and other 
disorders in the conjunctiva, such as 
benign and malignant lesions of the 
conjunctiva.
METHODS
Methods
Isolation of 
Genomic DNA
Genotyping 
rs4646903 (T> C)
VEGF 
examination
Sequencing results from 3 DNA samples; (a) sample S14 shows the sequencing results confirmed T> T 
wild type, (b) sample M7 shows the sequencing results confirmed C> C homozygote, and (c) M3 shows 
the sequences confirmed by T> C heterozygote
RESULT
CYP1A1m1 Polymorphism in Pterygium 
Polymorphism
Pterygium
Total
f(%)
P
Inflam
matory
f (%)
Non 
inflamm
atory
f (%)
Wild type (TT) 12 
(54,5)
10 (45,5) 22 
(100)
0,861
*
Mutant
Homozygote
7 
(50,0)
7 (50,0) 14 
(100)
Mutant
Heterozygote
16 
(47.1)
18 (52,9) 34 
(100)
Total 35 (50) 35 (50) 70 
(100)
RESULT
CYP1A1 polymorphisms divided into :
 wild type
 mutant homozygote
 mutant heterozygote. 
In both groups, mutant heterozygote 
polymorphisms were found to be higher than the 
wild type and homozygote types (34: 22: 14) 
CYP1A1 Level in Inflammatory and Non-Inflammatory Pterygium 
Variables
Pterygium
pInflammatory
Mean (SD)
Non-
inflammatory
Mean (SD)
CYP1A1 
Enzymes
Level
0,15 (0,06) 0,13 (0,07) 0,094*
RESULT
The mean CYP1A1 enzyme level in the inflammatory pterygium group was higher than non-
inflammatory pterygium, ie 0.15 (0.06) versus 0.13 (0.07).)
Protein p53 Level in Inflammatory and Non-Inflammatory Pterygium 
Variables
Pterygium
p
Inflammatory
Mean (SD)
Non-inlammatory
Mean (SD)
P53 protein in 
pterygium tissue
13,21 (8,20) 13,66 (11,37) 1,00*
The average p53 protein content in pterigium group was not inflamed higher than inflammatory 
pterygium, ie 13.66 (11.37) versus 13.21 (8.20 ). 
VEGF Level in Inflammatory and Non-Inflammatory Pterygium 
Variables
Pterygium
p
Inflamasi
Rerata (SD)
Tidak Inflmasi
Rerata (SD)
VEGF level 11,99 (7,24) 9,71 (5,14) 0,136*
The mean VEGF levels in the inflammatory pterygium group were higher than the non-inflammatory 
pterygium, ie 11.99 (7.24) versus 9.71 (5.14). 
Correlation of CYP1A1m1 Polymorphism with CYP1A1, Protein P53 and VEGF level on 
inflammatory and  non-inflammatory Pterygium
CYP1A1 enzyme level in wild type and mutant heterozygote group is higher in 
inflammatory, non inflammatory was higher in mutant homozygote polymorphism.  
p53 protein level in inflammatory pterygium group is higher in mutant heterozygote, while in 
non-inflammatory group the highest was the wild type
VEGF levels is highest in mutant homozygote in inflammatory group, whle in non-inflammatory 
group the VEGF level is highest in mutant homozygote group.
Discussion
• CYP1A1 m1 gene polymorphism was found in both pterygium groups. 
• Mutant heterozygote polymorphism is a more common in both 
groups 
• Tung et al (2010)  CYP1A1 protein expression in the mutant 
homozygote m2/m2 group is higher  did not match this study 
(mutant heterozygote group is higher)
CYP1A1m1 polymorphism (rs4646903) in inflammatory and non 
inflammatory Pterygium
Different levels of CYP1A1 enzyme in inflammatory and non inflammatory 
Pterygium
• CYP1A1 enzyme level in the inflammatory pterygium group was higher than non-
inflammatory group  no statistically significant different
• Tung et al (2010)  found a correlation between CYP1A1 polymorphism with 
BPDE-like DNA adduct formation in pterygium samples
• Cytochrome-P450 1A1 (CYP1A1) is involved in the metabolism of many 
xenobiotic compounds and endogenous lipophilic substances, which can activate 
procarcinogen into DNA reactive metabolites
Discussion
P53 mutants proven to activate 
Fibroblast Growth Factor (FGF), 
Epidermal Growth Factor (EGF) 
and Vascular Endothelial Growth 
Factor (VEGF)
The results of this study showed 
no significant differences 
between p53 protein levels in 
inflammatory and non 
inflammatory pterygium 
Differences in p53 protein levels in inflammatory and 
non inflammatory Pterygium
Discussion
Differences in VEGF levels in inflammatory 
and non inflammatory Pterygium
VEGF : cell 
proliferation, 
inflammation, 
connective tissue 
remodeling and 
angiogenesis 
No significant 
difference between 
VEGF levels in 
inflammatory and 
non inflammatory 
pterygium
Peng et al (2014) 
showed significant 
higher levels of VEGF 
in pterygium 
epithelial cells than 
normal conjunctival 
epithelium
The association of CYP1A1m1 polymorphism with CYP1A1, p53 and VEGF levels in 
inflammatory and non inflammatory pterygium 
There was no significant correlation between CYP1A1m1 polymorphism with 
mean of CYP1A1, p53, and VEGF enzyme levels in pterigium in both 
inflammatory and non-inflammatory groups
Peng (2014) and Young (2010)  CYP1A1 protein expression of the m1/m1 
genotype was not more significant than the m2/m2 genotype
Peng et al (2014)  variation of CYP1A1 allele could cause high BPDE-like 
DNA adduct formation rate, contributing to pterygium risk.
Conclusion
Polymorphisms in the CYP1A1 gene either in the form of mutant homozygote (CC), 
mutant heterozygote (TC), and wild type (TT). 
Mutant heterozygote is the most common form of polymorphism between the 
two groups of inflammatory and non-inflammatory groups. 
The mean levels of CYP1A1 enzyme and VEGF levels in inflammatory pterygium 
tissue were higher than non-inflammatory pterygium while the higher p53 
protein level in pterigium was found in non inflammatory pterygium compared to 
inflammatory pterygium, but statistically the difference was not significant. 
CYP1A1 gene polymorphisms have not been shown to be associated with levels of 
CYP1A1 enzymes, p53 protein and VEGF level in both pterygium groups.
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